Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
There's a chance that an investigational obesity drug late in its development stage could be fast-tracked for FDA approval. This would be under a new program launched by the regulator. A news article ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results